|Podcasts|April 29, 2021
Episode 81: Cancer Research Amid COVID
Author(s)Elaine Quilici
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer research going throughout the pandemic.
Advertisement
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, talks about the challenges and silver linings of continuing cancer research during the pandemic.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
3
Developing Better Drugs, Not Just More Drugs: Q&A with David Hung
4
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
5